Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1-Reference-Cited by-同舟云学术

Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1

Published:2017-10-30 Issue: Volume:8 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Chen Gui-hao,Xu Chuan-sheng,Zhang Jie,Li Qing,Cui He-he,Li Xiang-dong,Chang Li-ping,Tang Rui-jie,Xu Jun-yan,Tian Xia-qiu,Huang Pei-sen,Xu Jun,Jin Chen,Yang Yue-jin

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference111 articles.

1. Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128;Adlakha;Mol. Cancer,2014

2. The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells;Albrecht-Schgoer;Circulation,2012

3. Acute myocardial infarction;Anderson;N. Engl. J. Med.,2017

4. Tongxinluo improves cardiac function and ameliorates ventricular remodeling in mice model of myocardial infarction through enhancing angiogenesis;Bai;Evid. Based Compl. Alternat. Med.,2013

5. Thrombopoietin receptor agonists protect human cardiac myocytes from injury by activation of cell survival pathways;Baker;J. Pharmacol. Exp. Ther,2015

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs in Anticancer Drugs Hepatotoxicity: From Pathogenic Mechanism and Early Diagnosis to Therapeutic Targeting by Natural Products;Current Pharmaceutical Biotechnology;2024-10

2. The role of miR‐128 and MDFI in cardiac hypertrophy and heart failure: Mechanistic;Journal of Cellular and Molecular Medicine;2024-07

3. Tongxinluo capsule as a multi-functional traditional Chinese medicine in treating cardiovascular disease: A review of components, pharmacological mechanisms, and clinical applications;Heliyon;2024-07

4. Clinical effects and mechanisms of a Chinese patent medicine, Tongxinluo capsule, as an adjuvant treatment in coronary heart disease;Heliyon;2024-03

5. Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction;JAMA;2023-10-24